Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12 482 persons from the National Health and Nutritional Examination Survey von Landgren, O, Graubard, B I, Katzmann, J A, Kyle, R A, Ahmadizadeh, I, Clark, R, Kumar, S K, Dispenzieri, A, Greenberg, A J, Therneau, T M, Melton, L J, Caporaso, N, Korde, N, Roschewski, M, Costello, R, McQuillan, G M, Rajkumar, S V

Volltext

Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study von Afifi, S, Adel, N G, Devlin, S, Duck, E, Vanak, J, Landau, H, Chung, D J, Lendvai, N, Lesokhin, A, Korde, N, Reich, L, Landgren, O, Giralt, S, Hassoun, H

Volltext

Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial von Bhutani, M, Turkbey, B, Tan, E, Kemp, T J, Pinto, L A, Berg, A R, Korde, N, Minter, A R, Weiss, B M, Mena, E, Lindenberg, L, Aras, O, Purdue, M P, Hofmann, J N, Steinberg, S M, Calvo, K R, Choyke, P L, Maric, I, Kurdziel, K, Landgren, O

Volltext

P886: AFRICAN AMERICAN PATIENTS WITH SMOLDERING MULTIPLE MYELOMA MAY HAVE A LOWER RISK OF PROGRESSION COMPARED TO WHITE PATIENTS von Akhlaghi, T., Maclachlan, K., Korde, N., Mailankody, S., Lesokhin, A., Hassoun, H., Lu, S. X., Patel, D., Shah, U., Tan, C., Derkach, A., Lahoud, O., Landau, H. J., Shah, G. L., Scordo, M., Chung, D. J., Giralt, S. A., Usmani, S. Z., Landgren, O., Hultcrantz, M.

Volltext

S177: EVALUATING SERUM FREE LIGHT CHAIN RATIO AS A BIOMARKER FOR MULTIPLE MYELOMA von Akhlaghi, T., Maclachlan, K., Korde, N., Mailankody, S., Lesokhin, A., Hassoun, H., Lu, S. X., Patel, D., Shah, U., Tan, C., Derkach, A., Lahoud, O., Landau, H. J., Shah, G. L., Scordo, M., Chung, D. J., Giralt, S. A., Usmani, S. Z., Landgren, O., Hultcrantz, M.

Volltext

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies von Korde, Neha, Kristinsson, Sigurdur Y., Landgren, Ola

Volltext

Polymorphism of the erythropoietin gene promotor and the development of myelodysplastic syndromes subsequent to multiple myeloma von Landgren, O, Ma, W, Kyle, R A, Rajkumar, S V, Korde, N, Albitar, M

Volltext

Comparison of MALDI‐TOF mass spectrometry analysis of peripheral blood and bone marrow‐based flow cytometry for tracking measurable residual disease in patients with multiple myelo... von Eveillard, Marion, Rustad, Even, Roshal, Mikhail, Zhang, Yanming, Ciardiello, Amanda, Korde, Neha, Hultcrantz, Malin, Lu, Sydney, Shah, Urvi, Hassoun, Hani, Smith, Eric, Lesokhin, Alexander, Mailankody, Sham, Landgren, Ola, Thoren, Katie

Volltext

Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS) von Mailankody, Sham, Pfeiffer, Ruth M., Kristinsson, Sigurdur Y., Korde, Neha, Bjorkholm, Magnus, Goldin, Lynn R., Turesson, Ingemar, Landgren, Ola

Volltext

A Response Adapted Approach to Induction Treatment Yields acceptable Outcome in Patients with Multiple Myeloma (MM) undergoing Autologous Stem Cell transplantation (ASCT) von Shah, G.L, Weltz, J, Zhou, Q, Devlin, S.M, Landau, H, Chung, D.J, Lendvai, N, Lesokhin, A.M, Korde, N, Koehne, G, Giralt, S.A, Hassoun, H

Volltext

Second malignancies after multiple myeloma: from 1960s to 2010s von Thomas, Anish, Mailankody, Sham, Korde, Neha, Kristinsson, Sigurdur Y., Turesson, Ingemar, Landgren, Ola

Volltext

A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma von Korde, Neha, Carlsten, Mattias, Lee, Min-Jung, Minter, Alex, Tan, Esther, Kwok, Mary, Manasanch, Elisabet, Bhutani, Manisha, Tageja, Nishant, Roschewski, Mark, Zingone, Adriana, Costello, Rene, Mulquin, Marcia, Zuchlinski, Diamond, Maric, Irina, Calvo, Katherine R, Braylan, Raul, Tembhare, Prashant, Yuan, Constance, Stetler-Stevenson, Maryalice, Trepel, Jane, Childs, Richard, Landgren, Ola

Volltext

Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls von Shah, Urvi A, Rögnvaldsson, Sæmundur, Derkach, Andriy, Björkholm, Magnus, Turesson, Ingemar, David, Yael, Hultcrantz, Malin, Tan, Carlyn, Hassoun, Hani, Korde, Neha, Lesokhin, Alexander, Mailankody, Sham, Kristinsson, Sigurður Yngvi, Landgren, C Ola

Volltext

Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients von Kazandjian, Dickran, Hill, Elizabeth, Hultcrantz, Malin, Rustad, Evan H., Yellapantula, Venkata, Akhlaghi, Theresia, Korde, Neha, Mailankody, Sham, Dew, Alex, Papaemmanuil, Elli, Maric, Irina, Kwok, Mary, Landgren, Ola

Volltext

Dietary intake is associated with risk of multiple myeloma and its precursor disease von Thordardottir, Marianna, Lindqvist, Ebba K, Lund, Sigrun H, Costello, Rene, Burton, Debra, Steingrimsdottir, Laufey, Korde, Neha, Mailankody, Sham, Eiriksdottir, Gudny, Launer, Lenore J, Gudnason, Vilmundur, Harris, Tamara B, Landgren, Ola, Torfadottir, Johanna E, Kristinsson, Sigurdur Y

Volltext

Circulating Adiponectin Levels Differ Between Patients with Multiple Myeloma and its Precursor Disease von Hofmann, Jonathan N., Mailankody, Sham, Korde, Neha, Wang, Ye, Tageja, Nishant, Costello, Rene, Zingone, Adriana, Hultcrantz, Malin, Pollak, Michael N., Purdue, Mark P., Landgren, Ola

Volltext

Capture Rate of V(D)J Sequencing for Minimal Residual Disease Detection in Multiple Myeloma von Hultcrantz, Malin, Rustad, Even H, Yellapantula, Venkata, Jacob, Allison, Akhlaghi, Theresia, Korde, Neha, Mailankody, Sham, Lesokhin, Alexander M, Hassoun, Hani, Smith, Eric L, Lahoud, Oscar B, Landau, Heather J, Shah, Gunjan L, Scordo, Michael, Chung, David J, Giralt, Sergio, Papaemmanuil, Elli, Landgren, Ola

Volltext

Efficient Ultrasound Synthesis, Characterizations and Antimicrobial Screening of Novel Cyclic β-Diketones von N. S. KORDE, N. S. KORDE, S. T. GAIKWAD, S. T. GAIKWAD, B. C. KHADE, B. C. KHADE, A. S. RAJBHOJ, A. S. RAJBHOJ

Volltext

Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma von Landgren, O, Hofmann, JN, McShane, CM, Santo, L, Hultcrantz, M, Korde, N, Mailankody, S, Kazandjian, D, Murata, K, Thoren, K, Ramanathan, L, Dogan, A, Rustad, E, Lu, SX, Akhlaghi, T, Kristinsson, SY, Bjorkholm, M, Devlin, S, Purdue, MP, Pfeiffer, RM, Turesson, I

Volltext

Ixazomib and dexamethasone in high risk smoldering multiple myeloma: A clinical and correlative pilot study von Mailankody, Sham, Salcedo, Meghan, Tavitian, Elizabet, Korde, Neha, Lendvai, Nikoletta, Hassoun, Hani, Lesokhin, Alexander M., Lahoud, Oscar Boutros, Smith, Eric L., Hultcrantz, Malin, Devlin, Sean M., Landgren, Ola

Volltext